Dezhan Health released its 2026 interim report. The company's total operating revenue was 143 million yuan, down 14.26% year-on-year. Net profit attributable to the parent company was a loss of 58.1986 million yuan, with the loss widening year-on-year. Net cash flow from operating activities was a negative 52.2939 million yuan, down 288.09% year-on-year. The company's asset-liability ratio was 5.70%, gross margin was 37.11%, ROE was negative 1.27%, and diluted earnings per share was negative 0.03 yuan. The number of shareholders was 50,900, and the top ten shareholders held 48.97% of the total share capital.
Dezhan HealthCare Co LtdNet loss widened and operating cash flow turned sharply negative.
